Conference Coverage
Conference Coverage
Capecitabine maintenance improved DFS, not OS, in TNBC patients
The 5-year disease-free survival rate was 83% in the capecitabine arm and 73% in the observation arm.
Conference Coverage
PPI added to chemo improves breast tumor response rate
Conference Coverage
First-line nivolumab plus platinum/etoposide effective in extensive-stage SCLC
Latest News
Despite guidelines, controversy remains over corticosteroids in COVID-19
There are conflicting recommendations on the use of corticosteroids in critically ill patients with COVID-19.
Conference Coverage
Upfront pembrolizumab doubles PFS in MSI-H/dMMR metastatic colorectal cancer
Pembrolizumab outperformed chemotherapy in patients with microsatellite-instability high/mismatch repair-deficient metastatic colorectal cancer....
Conference Coverage
Moving on up: Maintenance therapy extends OS in bladder cancer
Conference Coverage
Adjuvant osimertinib extends DFS in localized NSCLC
Osimertinib reduced the risk of disease recurrence or death by 79% in patients with EGFR-mutated non–small cell lung cancer.
Conference Coverage
Active cancer increases death risk in patients with COVID-19
Conference Coverage
COVID-19: Psychiatrists assess geriatric harm from social distancing
“Certainly the appalling number of deaths in nursing homes is the No. 1 horror of the pandemic.”
Conference Coverage
Social isolation tied to higher risk of cardiovascular events, death
“These results are especially important in the current times of social isolation during the coronavirus crisis.”